Burk, Oliver; Kuzikov, Maria; Kronenberger, Thales 
; Jeske, Judith; Keminer, Oliver ; Thasler, Wolfgang E. ; Schwab, Matthias ; Wrenger, Carsten ; Windshügel, Bjorn
Fonte: Archives of Toxicology. Unidade: ICB
Assuntos: PARASITOLOGIA, ANTAGONISMO DE DROGAS, CÉLULAS KUPFFER
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BURK, Oliver et al. Identification of approved drugs as potent inhibitors of pregnane X receptor activation with differential receptor interaction profiles. Archives of Toxicology, v. 92, p. 1435-1451, 2018Tradução . . Disponível em: https://doi.org/10.1007/s00204-018-2165-4. Acesso em: 18 jul. 2024.APA
Burk, O., Kuzikov, M., Kronenberger, T., Jeske, J., Keminer, O., Thasler, W. E. , et al. (2018). Identification of approved drugs as potent inhibitors of pregnane X receptor activation with differential receptor interaction profiles. Archives of Toxicology, 92, 1435-1451. doi:10.1007/s00204-018-2165-4NLM
Burk O, Kuzikov M, Kronenberger T, Jeske J, Keminer O, Thasler W E , Schwab M, Wrenger C, Windshügel B. Identification of approved drugs as potent inhibitors of pregnane X receptor activation with differential receptor interaction profiles [Internet]. Archives of Toxicology. 2018 ; 92 1435-1451.[citado 2024 jul. 18 ] Available from: https://doi.org/10.1007/s00204-018-2165-4Vancouver
Burk O, Kuzikov M, Kronenberger T, Jeske J, Keminer O, Thasler W E , Schwab M, Wrenger C, Windshügel B. Identification of approved drugs as potent inhibitors of pregnane X receptor activation with differential receptor interaction profiles [Internet]. Archives of Toxicology. 2018 ; 92 1435-1451.[citado 2024 jul. 18 ] Available from: https://doi.org/10.1007/s00204-018-2165-4
